Pursuant to the provisions of regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Wellness has informed that the meeting of the Board of Directors of the Company will be held on Thursday, February 2, 2023 to consider, apart from other agenda items, approval of unaudited financial results for the quarter and nine months ended on December 31, 2022. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015, shall remain closed until February 5, 2023 and shall open for trading on and from February 6, 2023 for all the Directors and Designated Persons.
The above information is a part of company’s filings submitted to BSE.
